Incidence of urinary tract infections in patients with type 2 diabetes receiving ertugliflozin, placebo or active comparator

被引:0
|
作者
Hickman, M. A. [1 ]
Patel, S. [2 ]
Lauring, B. [2 ]
Terra, S. G. [3 ]
Johnson, S. [4 ]
Huyck, S. [2 ]
Mancuso, J. P. [1 ]
机构
[1] Pfizer Inc, Groton, CT 06340 USA
[2] Merck & Co Inc, Kenilworth, NJ USA
[3] Pfizer Inc, Andover, MA USA
[4] Pfizer Inc, Collegeville, PA USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
630
引用
收藏
页码:S306 / S306
页数:1
相关论文
共 50 条
  • [1] URINARY TRACT INFECTIONS: INCIDENCE IN PATIENTS WITH TYPE 2 DIABETES MELLITUS
    Santosh, A. A.
    Pasumarthy, P.
    Murthy, Krishna M.
    VALUE IN HEALTH, 2018, 21 : S113 - S113
  • [2] Prevalence and incidence of urinary tract and genital infections among patients with and without type 2 diabetes
    Nichols, Gregory A.
    Brodovicz, Kimberly G.
    Kimes, Teresa M.
    Deruaz-Luyet, Anouk
    Bartels, Dorothee B.
    JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2017, 31 (11) : 1587 - 1591
  • [3] Characterization of the Risk for Urinary Tract Infections in Patients With Type 2 Diabetes
    Iglay, Kristy
    Fu, Alex Z.
    Qiu, Ying
    Engel, Samuel S.
    Shankar, Ravi
    Davies, Michael J.
    Brodovicz, Kimberly G.
    DIABETES, 2013, 62 : A394 - A394
  • [4] Predictive Factors for Urinary Tract Infections in Patients with Type 2 Diabetes
    Sorescu, Teodora
    Cosnita, Andrei
    Braha, Adina
    Timar, Romulus
    Timar, Bogdan
    Licker, Monica
    Lazar, Sandra
    Gaita, Laura
    Albai, Oana
    Popescu, Simona
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (24)
  • [5] Assessment of liver function in patients with type 2 diabetes receiving ertugliflozin
    Gallo, S.
    Calle, R. A.
    Terra, S. G.
    Pong, A.
    Tarasenko, L.
    Raji, A.
    DIABETOLOGIA, 2019, 62 : S341 - S341
  • [6] ASSESSMENT OF LIVER FUNCTION IN PATIENTS WITH TYPE 2 DIABETES MELLITUS RECEIVING ERTUGLIFLOZIN
    Gallo, Silvina
    Calle, Roberto
    Terra, Steven
    Pong, Annpey
    Tarasenko, Lisa
    Raji, Annaswamy
    HEPATOLOGY, 2019, 70 : 1261A - 1261A
  • [7] Urinary tract infections in patients with type 2 diabetes mellitus with pharmacological glucosuria
    Sturov, N., V
    Popov, S., V
    Mamporia, N. K.
    Mager, A. A.
    TERAPEVTICHESKII ARKHIV, 2020, 92 (11) : 106 - 109
  • [8] Assessment of adverse renal effects in patients with type 2 diabetes receiving ertugliflozin
    Terra, S. G.
    Patel, S.
    Hickman, A.
    Frederich, R.
    Lauring, B.
    Johnson, S.
    Huyck, S.
    Mancuso, J. P.
    DIABETOLOGIA, 2018, 61 : S300 - S301
  • [9] Incidence of urinary tract and genital infections among patients with and without diabetes
    Nichols, G. A.
    Brodovicz, K. G.
    Bartels, D. B.
    DIABETOLOGIA, 2016, 59 : S511 - S511
  • [10] Urinary tract infections in patients with diabetes
    Stapleton, A
    AMERICAN JOURNAL OF MEDICINE, 2002, 113 : 80S - 84S